http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800229-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104800229-B |
| titleOfInvention | A kind of compound sulfadiazine suspension and preparation method thereof |
| abstract | The invention discloses a kind of compound sulfadiazine suspension, it is by sulphadiazine, TMP, sodium hydroxide, suspending agent A, suspending agent B, surfactant and water for injection.The preparation method of the present invention：Sulphadiazine and TMP are milled to 400 700nm；TMP is added in suspending agent A, the first lysate is dissolved to obtain；Water for injection is taken, 45 DEG C are heated to, sulphadiazine, suspending agent B is added, obtains the second lysate；Remaining water for injection is taken, is heated to, sodium hydroxide dissolving is added；The first lysate is heated to 60 DEG C 65 DEG C successively, the second lysate is heated to 40 50 DEG C, remixed, the 3rd lysate and surfactant are added in the proportion container, stirred, the 4th lysate is obtained；Obtained 4th lysate is added to high-shear homogenizer and sheared 10 20 minutes, and filtrate is sterilized 30 minutes under 100 130 DEG C, 0.1 0.2Mpa.Improve absorptivity low, reduce acetyl rate, and crystallization content tails off in urine. |
| priorityDate | 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.